Becton Dickinson and Company (BDX)vsMiniMed Group, Inc. Common Stock (MMED)
BDX
Becton Dickinson and Company
$180.94
-0.24%
HEALTHCARE · Cap: $48.05B
MMED
MiniMed Group, Inc. Common Stock
$21.79
-1.09%
HEALTHCARE · Cap: $6.55B
Smart Verdict
WallStSmart Research — data-driven comparison
Becton Dickinson and Company generates 598% more annual revenue ($22.48B vs $3.22B). BDX leads profitability with a 4.2% profit margin vs -9.7%. BDX earns a higher WallStSmart Score of 52/100 (C-).
BDX
Buy52
out of 100
Grade: C-
MMED
Avoid33
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+11.0%
Fair Value
$202.87
Current Price
$180.94
$21.93 discount
Intrinsic value data unavailable for MMED.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Reasonable price relative to book value
16.6% revenue growth
Areas to Watch
Premium valuation, high expectations priced in
ROE of 3.9% — below average capital efficiency
4.2% margin — thin
Earnings declined 31.4%
0.0% earnings growth
ROE of 0.0% — below average capital efficiency
Operating margin of 0.2%
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : BDX
The strongest argument for BDX centers on Price/Book. PEG of 1.11 suggests the stock is reasonably priced for its growth.
Bull Case : MMED
The strongest argument for MMED centers on Debt/Equity, Price/Book, Revenue Growth. Revenue growth of 16.6% demonstrates continued momentum.
Bear Case : BDX
The primary concerns for BDX are P/E Ratio, Return on Equity, Profit Margin. Thin 4.2% margins leave little buffer for downturns.
Bear Case : MMED
The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.
Key Dynamics to Monitor
BDX profiles as a value stock while MMED is a growth play — different risk/reward profiles.
MMED is growing revenue faster at 16.6% — sustainability is the question.
BDX generates stronger free cash flow (509M), providing more financial flexibility.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BDX scores higher overall (52/100 vs 33/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Becton Dickinson and Company
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Visit Website →MiniMed Group, Inc. Common Stock
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?